Aditxt Stock (NASDAQ: ADTX) stock price, news, charts, stock research, profile.
Open | $2.180 |
Close | - |
Volume / Avg. | 21.317K / 357.280K |
Day Range | 1.980 - 2.225 |
52 Wk Range | 1.950 - 68.080 |
Market Cap | $3.507M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 12.87% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aditxt (NASDAQ: ADTX) through any online brokerage.
Other companies in Aditxt’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Aditxt (NASDAQ: ADTX) was reported by HC Wainwright & Co. on Wednesday, September 6, 2023. The analyst firm set a price target for 61.00 expecting ADTX to rise to within 12 months (a possible 2796.35% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aditxt (NASDAQ: ADTX) is $2.1061 last updated Today at May 15, 2024 at 2:47 PM EDT.
There are no upcoming dividends for Aditxt.
Aditxt’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Aditxt.
Aditxt is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.